Tuesday , October 24 2017
Home / Resources / Clinical Presentations / Improving Outcomes with SGLT-2 Inhibitors in Challenging T2DM Patients, Part 3

Improving Outcomes with SGLT-2 Inhibitors in Challenging T2DM Patients, Part 3

In this third set of a series of four Homerun Slides on SGLT-2 inhibitor medications, we cover LX4211, an SGLT-1 and SGLT-2 dual inhibitor, and then explore some of the safety concerns around SGLT-2 inhibitors including the safety of this drug class for older patients. We also review some of the data on genital mycotic infections, an issue that has been in the forefront of some clinician’s concerns in prescribing SGLT-2’s….

To download this Homerun Slides series in PowerPoint (.ppt) format, just use this link: Improving Outcomes with SGLT-2 Inhibitors in Challenging T2DM Patients, Part 3

Other sets in this series (.ppt) format:

Improving Outcomes with SGLT-2 Inhibitors in Challenging T2DM Patients, Part 1
Improving Outcomes with SGLT-2 Inhibitors in Challenging T2DM Patients, Part 2
Improving Outcomes with SGLT-2 Inhibitors in Challenging T2DM Patients, Part 4 

To download the entire series (74 slides) in PDF format, just use this link: Improving Outcomes with SGLT2 Inhibitors in Challenging T2DM Patients 

See more SGLT-2 Resources